Home › Funds › GLENMEDE FUND INC › Disciplined U.S. Small Cap Equity Portfolio
Fund family: GLENMEDE FUND INC · Filed by GLENMEDE FUND INC (CIK 835663) · SEC series S000059608
Share classes and tickers: GQSCX (C000195216), GQSIX (C000260455)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,167 with, 9 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as GLENMEDE FUND INC’s manager page (9,904 ballot items across 13 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | GLENMEDE FUND INC | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 92.6% | 1,137 | 94.6% | 8,897 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 58.5% | 193 |
Each ballot item this fund voted is set against the votes of the other GLENMEDE FUND INC funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most GLENMEDE FUND INC funds on all 25 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 96.9% of this fund’s 1,176 such votes could be given a sector; the other 36 (3.1%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 290 | 2 | 0.7% |
| Finance | 169 | 0 | 0.0% |
| Health Care | 167 | 3 | 1.8% |
| Technology | 156 | 1 | 0.6% |
| Industrials | 142 | 3 | 2.1% |
| Real Estate | 95 | 0 | 0.0% |
| Energy | 50 | 0 | 0.0% |
| Utilities | 44 | 0 | 0.0% |
| Telecommunications | 11 | 0 | 0.0% |
| Consumer Staples | 7 | 0 | 0.0% |
| Miscellaneous | 5 | 0 | 0.0% |
| Basic Materials | 4 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 817 | 3 |
| Say-on-Pay | 133 | 2 |
| Audit-related | 122 | 0 |
| Compensation | 47 | 0 |
| Corporate Governance | 33 | 4 |
| Capital Structure | 18 | 0 |
| Extraordinary Transactions | 11 | 0 |
| Shareholder Rights and Defenses | 3 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | June 9, 2026 | $84,727 | 5 | 0 |
| CareDx, Inc. | June 11, 2026 | $76,300 | 9 | 0 |
| 10x Genomics, Inc. | June 4, 2026 | $74,291 | 5 | 0 |
| Pacira Biosciences, Inc. | June 9, 2026 | $48,336 | 10 | 3 |
| The Manitowoc Company, Inc. | May 5, 2026 | $42,813 | 12 | 0 |
| Allient Inc. | May 6, 2026 | $42,786 | 8 | 0 |
| Par Pacific Holdings, Inc. | April 30, 2026 | $39,650 | 14 | 0 |
| Penguin Solutions, Inc. | February 6, 2026 | $38,914 | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposal | Withhold | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposal | Withhold | For |
| May 1, 2026 | AMN Healthcare Services, Inc. | A shareholder proposal entitled: "Independent Board Chairman." Shareholder proposal | For | Against |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | For | Against |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | For | Against |
| May 14, 2026 | The Western Union Company | Stockholder proposal regarding stockholder right to act by written consent Shareholder proposal | For | Against |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two years | Against | For |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three years | Against | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
1,184 ballot items at 133 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Disciplined U.S. Small Cap Equity Portfolio (GQSCX) voted at 133 shareholder meetings of 125 companies, on 1,184 ballot items in all. Where management made a recommendation, the fund followed it on 99.2% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (4 of its votes against management). It voted on 7 shareholder proposals. It voted FOR the board's own proposals less often than GLENMEDE FUND INC's funds as a whole (92.6% against 94.6%). It voted the same way as most GLENMEDE FUND INC funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of GLENMEDE FUND INC’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.